Petros Pharmaceuticals, Inc. (PTPI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
66.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $5.11M | $5.82M | $5.99M | $7.81M | $9.56M | — |
| Cost of Revenue | — | $1.21M | $1.63M | $2.29M | $1.60M | $4.05M | — |
| Gross Profit | — | $3.90M | $4.19M | $3.70M | $6.21M | $5.51M | — |
| Operating Income | -$4.64M | -$4.63M | -$13.62M | -$19.92M | -$18.05M | -$17.28M | — |
| Net Income | $1.91M | -$14.32M | -$8.16M | -$20.04M | -$8.99M | -$20.59M | — |
| EPS (Diluted) | $-1.56 | $-83.47 | $-6.35 | $-9.68 | $-8.25 | $-3.85 | — |
| Total Assets | $5.16M | $10.64M | $33.80M | $32.42M | $67.39M | $69.85M | — |
| Total Liabilities | $2.29M | $18.10M | $21.32M | $15.72M | $31.85M | $52.38M | — |
| Shareholders' Equity | $2.87M | -$7.47M | $12.07M | $16.70M | $35.54M | $17.47M | $8.02M |
| Cash & Equivalents | $5.14M | $1.72M | $13.34M | $9.43M | $23.85M | $17.14M | — |
| Operating Cash Flow | -$6.73M | -$2.60M | -$7.63M | -$12.80M | -$11.86M | -$15.31M | — |
| Capital Expenditures | — | $24.6K | — | — | — | $4.6K | — |
| Shares Outstanding | 42.28M | 421.1K | 2.99M | 2.08M | 2.07M | 9.71M | — |